Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s530516 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Yang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic of China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, People's Republic of China.
- China Academy of Chinese Medical Sciences, Suzhou, 215100, People's Republic of China.
- Shanxi Province Cancer Hospital/Shanxi Hospital Afiliated to Cancer Hospital, Chinese Academy of Medical, Sciences/Cancer Hospital Afiliated to Shanxi Medical University, Shanxi, 030013, People's Republic of China.
- Graduate School, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.
ORCID-Profile: Yang Wang
Zitieren
APA
Wang, Y., Yang, R., Shi, Y., & Liu, S. (2025). Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s530516
Vancouver
Wang Y, Yang R, Shi Y, Liu S. Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s530516
BibTeX
@article{Wang2025,
author = {Wang, Yang and Yang, Rui and Shi, Youyang and Liu, Sheng},
title = {Elucidating the Pharmacological Basis of Xianling Cifang Granules Against Breast Cancer. A Metabolomic Profiling Study},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s530516}
}
EUVIMED